- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: trastuzumab
Total 1298 results
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingGlioblastoma | Brain Cancer | Metastatic Cancer | Recurrent Glioblastoma | Leptomeningeal MetastasisUnited States
-
MedSIRDaiichi Sankyo, Inc.Not yet recruitingBreast Cancer | Metastatic Breast Cancer
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Youzhi ZhuRecruitingBreast Cancer FemaleChina
-
IsalaRecruitingOncology | Infusion ReactionNetherlands
-
National University Hospital, SingaporeNot yet recruitingOther Solid Tumors | HER2+ Advanced Breast Cancer
-
Sunnybrook Health Sciences CentreSeagen Inc.; Biocon BiologicsRecruitingHER2-positive Breast Cancer | LMDCanada
-
Wuhan Union Hospital, ChinaRecruitingBreast Cancer | NeoadjuvantChina
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaAustria, Belgium, Germany, Italy
-
Cancer Institute and Hospital, Chinese Academy...Chinese Academy of Medical Sciences Cancer Hospital,Shanxi Center; Chinese... and other collaboratorsNot yet recruitingBreast Cancer | Neoadjuvant TherapyChina
-
RemeGen Co., Ltd.Recruiting
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
wang shusenRecruiting
-
Peking University Cancer Hospital & InstituteRecruiting
-
University of SouthamptonAstraZeneca; Natera, Inc.RecruitingGastrooesophageal CancerUnited Kingdom
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Institut CurieSeagen Inc.RecruitingHER2-positive Breast CancerFrance
-
Fudan UniversityNot yet recruitingTriple-Negative Breast CancerChina
-
Daiichi Sankyo, Inc.AstraZenecaRecruiting
-
Hoffmann-La RocheRecruiting
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMetastatic Breast CancerItaly
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Karolinska University HospitalRecruiting
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Mayo ClinicRecruitingBreast NeoplasmUnited States
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Fudan UniversityRecruitingHER2 Positive Early Breast CancerChina
-
Taizhou HospitalRecruiting
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Gruppo Oncologico del Nord-OvestRecruitingColorectal Cancer | Resectable Colorectal CarcinomaItaly
-
Fudan UniversityNot yet recruiting
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Yantai Yuhuangding HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
UNICANCERSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisFrance
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingColorectal Neoplasms | Ovarian Neoplasms | Solid Tumor | Gallbladder Neoplasms | Prostatic Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Haematological Malignancy | Urinary Bladder Neoplasm | Skin Neoplasm | Salivary Gland NeoplasmUnited Kingdom
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Shanghai Fosun Pharmaceutical Industrial Development...Recruiting
-
Consorzio OncotechRoche Pharma AGRecruiting
-
Yonsei UniversityNot yet recruitingHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Spanish Breast Cancer Research GroupAstraZenecaRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerSpain
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Oslo University HospitalRecruitingMetastatic Colorectal CancerNorway
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina